CSMG Technologies Announces 450 Successful Lung Surgical Procedures Completed.

CORPUS CHRISTI, Texas -- CSMG Technologies, Inc. (OTCBB:CTUM), a technology management company focused on commercializing human live tissue bonding devices, announced today that Kiev City Hospital #17, performed 450 successful lung surgeries using the Company's tissue welding technology in both open and thoracoscopic procedures.

The welding technology was used in surgical procedures that included: pneumolysis, pneumotomy, lymphodisseciton, lymph node sampling, wedge lung resections, sealing of peripheral part of the lung vessels. The welding technology is being routinely used for sealing lungs in cases of spontaneous pneumothorax and prolonged air leakage including bullous emphysema where the lung is repaired without removal of lung sections - no sutures, staples, glues or sealants were used.

Dr. Makarov holder of Thoracic Surgery and pulmonology chair at Kiev Medical Academy for Postgraduate Studies said, "There was not one case where there was lung air leakage or infection after the surgical procedure. The surgical procedures on lungs are done almost bloodlessly and the tissue welding method allows us to do surgeries much faster compared to the conventional techniques of suturing and stapling."

CSMG owns the technology and exclusive world rights to the medical device through Live Tissue Connect, Inc., a subsidiary corporation formed for the development and exploitation of the platform technology.

Donald S. Robbins, president and CEO of CSMG, said, "The main advantage of this breakthrough is a shortened surgery time and no foreign staples or sutures are left in the lung. The surgery leaves the healthy lung lobe portion functional in the body while removing the diseased lung lobe tissue."

The tissue welding/bonding technology for repair and reconnection of tissue and hollow organs is smokeless, with little heat migration in the tissue, results in no necrosis and is without the use of foreign matter or conventional wound-closing devices, such as of staples, sutures, glues or sealant. The procedures are almost bloodless. Unlike other tissue coagulation methods that tend to destroy tissue by charring, searing and necrosis, the CSMG-patented technology bonds and reconnects incised tissue using a patented low-heat delivery method aimed at restoring the normal functions of the live organs and tissue. The technology leaves little or no scar visible to the naked eye.

About CSMG Technologies' Tissue Welding/Bonding Technology